Florida Urology Partners

What Florida Urology Partners does

Florida Urology Partners is a privately held, physician-led urology and radiation oncology practice headquartered in Tampa, Florida. The group operates 19 outpatient office locations across the Tampa Bay region spanning Hillsborough, Pinellas, Pasco, and Hernando counties, staffed by nearly 40 physicians and board-certified oncologists with subspecialty training in endourology, robotics, female urology, male infertility, and genitourinary oncology. Patients are treated across the full spectrum of urological conditions, with primary clinical focus on prostate, kidney, bladder, testicular, and adrenal cancers, alongside benign prostatic hyperplasia, kidney stones, incontinence, urinary tract infections, erectile dysfunction, and male infertility.

The practice's clinical capability is built on a portfolio of advanced surgical and diagnostic platforms, including the DaVinci Surgical System for robotic-assisted prostatectomy, nephrectomy, cystectomy, and adrenalectomy; the UroNav MR/ultrasound fusion biopsy system for targeted prostate lesion sampling; Axonics sacral neuromodulation for overactive bladder and incontinence; GreenLight Laser Therapy and REZUM water vapor therapy for BPH; and UroLift for in-office prostate enlargement treatment. In June 2023, the group performed the first transvesical radical prostatectomy in Florida using the da Vinci single-port system, establishing a same-day-discharge capability with materially improved continence outcomes.

Commercially, the practice operates a fee-for-service model reimbursed primarily through third-party insurance networks, with participation across 25+ payer contracts including Aetna, BCBS, Cigna, Humana, Medicare, and United Healthcare. Since 2021, Florida Urology Partners has operated under a strategic alignment with Tampa General Hospital as part of the TGH Physician Enterprise and TGH Cancer Institute, while maintaining surgical privileges at St. Joseph's Hospital, AdventHealth, and HCA Florida facilities. Patient access combines direct-to-consumer self-referral with primary care and hospital-based referrals across the regional health system ecosystem.

Name

Florida Urology Partners

Legal name

Florida Urology Partners, LLC

Website

https://floridaurologypartners.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Florida Urology Partners is a private Tampa-based urology and radiation oncology practice with nearly 40 physicians serving patients across 19 Tampa Bay locations. It offers genitourinary cancer care, robotic surgery, advanced diagnostics, and subspecialty urological treatments, aligned with Tampa General Hospital's Cancer Institute.

Ownership category

akta.pro rank

Product category

Specialty Urology and Urological Oncology Services

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

General Urology (HLAKAOAA)

akta.pro secondary industries

Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC), Urologic Oncology (HLAKAOAB)

Keywords

• Urology services
• Urological oncology care
• Robotic surgery
• Radiation oncology
• Urological diagnostics

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices20 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Patient Care Services: Revenue generated from providing medical consultations, diagnostic procedures, treatments, and surgeries to patients. Services are billed to insurance providers or patients directly based on the fee-for-service healthcare model.
2. Insurance Reimbursement: The practice accepts numerous insurance plans including Aetna, BCBS, Cigna, Humana, Medicare, United Healthcare, and others. Services are reimbursed through standard healthcare insurance billing.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Florida Urology Partners provides integrated urological and radiation oncology services — including diagnostic evaluation (PSA screening, cystoscopy, MR/ultrasound fusion biopsy), minimally invasive and robotic surgery (da Vinci prostatectomy, nephrectomy, cystectomy, adrenalectomy, TURBT), in-office procedures (UroLift, REZUM, GreenLight laser, Axonics sacral neuromodulation), and surgical services (vasectomy, vasectomy reversal, circumcision, kidney stone management) — delivered through 19 Tampa Bay–area offices by nearly 40 board-certified urologists and radiation oncologists.

Product overview

Florida Urology Partners is a comprehensive urology group offering integrated urological and radiation oncology services across 19 locations in the Tampa Bay region. Their portfolio includes surgical procedures (robotic cancer surgery, DaVinci procedures, TURBT, vasectomy), diagnostic services (cystoscopy, PSA screening, UroNav fusion biopsy), and treatment technologies (UroLift, Axonics therapy, GreenLight laser, REZUM vapor therapy). They serve approximately 40 physicians and board-certified oncologists treating conditions including prostate cancer, kidney cancer, bladder cancer, BPH, kidney stones, and various urological conditions.

Differentiator

Problem solved

Functional benefit

Products and services

• General Urology Consultation and Diagnostic Services New patient evaluations and diagnostic workups for general urological conditions including kidney stones, urinary tract infections, incontinence, voiding dysfunction, prostatitis, and low testosterone. Available for adult men and women across all 19 practice locations.
• Targeted Fusion Biopsy (UroNav) MR/ultrasound fusion biopsy system that fuses pre-biopsy MRI images with real-time ultrasound-guided biopsy images for precise prostate cancer detection. Indicated for men with suspected prostate cancer based on PSA levels or prior imaging findings.
• Robotic Cancer Surgery Minimally invasive robotic surgery for cancer treatment including nephrectomy, partial nephrectomy, prostatectomy, cystectomy, and adrenalectomy using surgeon-controlled robotic systems. Performed at hospital facilities for adult patients with genitourinary cancers.
• DaVinci Surgical System Procedures Robotic-assisted surgery platform enabling precise minimally invasive urologic procedures with high dexterity and 3D visualization. Used for prostatectomy, nephrectomy, cystectomy, and adrenalectomy in patients requiring urologic cancer surgery.
• Transvesical Radical Prostatectomy with Da Vinci Single-Port System Single-port transvesical approach to radical prostatectomy through the bladder, allowing same-day discharge and approximately 50% immediate continence post-surgery. Indicated for select men with prostate cancer.
• Transurethral Resection of Bladder Tumor (TURBT) Surgical treatment for bladder cancer using cystoscope insertion through the urethra with high-frequency electric current to remove and burn cancer cells. Performed for patients diagnosed with non-muscle-invasive bladder tumors.
• UroLift System Treatment Minimally invasive BPH treatment using tiny permanent implants to lift and hold enlarged prostate tissue out of the way, typically performed in-office with rapid recovery. Indicated for men with benign prostatic hyperplasia.
• GreenLight Laser Therapy Minimally invasive laser treatment for BPH combining the effectiveness of traditional TURP with fewer side effects, enabling rapid urine flow improvement with a virtually bloodless procedure. Indicated for men with benign prostatic hyperplasia.
• Axonics Sacral Neuromodulation Therapy Implantable device providing gentle stimulation to the nerves controlling bladder and bowel function for treatment of overactive bladder, fecal incontinence, and urinary retention. Designated Axonics Center of Excellence. Indicated for adults with refractory bladder or bowel dysfunction.
• REZUM Prostate Vapor Therapy Water vapor thermal therapy for treating enlarged prostate using controlled convective water vapor energy to ablate prostate tissue. Indicated for men with BPH.
• Vasectomy Permanent male sterilization procedure involving division of the vas deferens, available as a conventional scalpel method or no-scalpel technique performed under local anesthesia. Indicated for men seeking permanent contraception.
• Vasectomy Reversal Reconstructive procedure to reverse vasectomy, with success rates varying based on time since original vasectomy and other factors. Indicated for men seeking to restore fertility after vasectomy.
• Cystoscopy Diagnostic procedure using a thin lighted cystoscope to examine the inside of the bladder and urethra, allowing visualization and collection of small biopsies or urine samples. Indicated for patients with hematuria, recurrent UTIs, or suspected bladder pathology.
• PSA Screening Prostate-specific antigen blood test screening recommended for men aged 50-70 to detect prostate cancer early, credited with a 40 percent reduction in prostate cancer deaths. Offered as a routine screening service for adult men.

Quantifiable outcome

• PSA screening has decreased prostate cancer deaths by 40 percent
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• Tampa General HospitalflagshipStrategic or Co-development Partner · 1 January 2021Florida Urology Partners aligned with Tampa General Hospital in 2021 as part of its Physician Enterprise. The practice is now part of the TGH Cancer Institute and other support services to ensure world-class innovative care across Florida. Florida Urology Partners physicians perform robotic surgeries at TGH, which achieved its 10,000th robot-assisted surgery milestone in 2022 and received Center of Excellence accreditation in Robot-Assisted Surgery.
• Axonics, Inc.coreTechnology or IntegrationAxonics, Inc. designated Florida Urology Partners as an Axonics Center of Excellence, recognizing the team's expertise with Axonics Therapy for treating overactive bladder, fecal incontinence, and urinary retention. The designation specifically recognizes Dr. Osvaldo Padron's expertise with Axonics Therapy and the quality of patient outcomes achieved.
• St. Joseph's HospitalcoreStrategic or Co-development PartnerMultiple Florida Urology Partners physicians maintain surgical privileges at St. Joseph's Hospital and St. Joseph's Hospital - South. Dr. David Hochberg serves as Chief of Urology at St. Joseph's Hospital. The practice has contributed to building the robotics program at the hospital.
• AdventHealthcoreStrategic or Co-development PartnerFlorida Urology Partners physicians including Dr. Ross Simon, Dr. Alonso Alvarez, and Dr. Stephanie Stillings operate at AdventHealth facilities including AdventHealth Carrollwood and AdventHealth Wesley Chapel.
• HCA FloridacoreStrategic or Co-development PartnerFlorida Urology Partners maintains affiliations with HCA Florida South Tampa Hospital and other HCA Florida facilities. Several physicians including Dr. Rudolph Acosta maintain privileges at AdventHealth Tampa (formerly Florida Hospital Tampa) which is part of the AdventHealth system.
• Urology of Virginia / Eastern Virginia Medical SchoolminorStrategic or Co-development PartnerDr. Mohit Sirohi completed his Endourology fellowship at Urology of Virginia/Eastern Virginia Medical School in Virginia Beach. This represents an academic/training partnership relationship.
• Peter MacCallum Cancer Centre and Royal Melbourne HospitalminorStrategic or Co-development PartnerDr. Reid Graves completed a fellowship in Robotic and Laparoscopic Surgery at Peter MacCallum Cancer Centre and Royal Melbourne Hospital in Melbourne, Australia, representing an international training/academic partnership.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Integrated Medical Professionals (United Urology Group): Multi-state urology group formed from the combination of several large practices including Adult and Pediatric Urology and larger NY/NJ groups. Closely comparable business model — physician partnership operating multiple locations with robotic surgery and oncology focus.
• Carolina Urology Partners: Multi-physician urology practice in the Carolinas offering comprehensive urology services including oncology, robotic surgery, and female urology. Comparable size and structure to Florida Urology Partners.
• The Urology Group: Single-specialty urology group serving Greater Cincinnati with multiple offices, offering oncology, robotic surgery, and female urology. Comparable in structure, size, and service mix; part of large consolidated independent urology networks.
• Chesapeake Urology: Large multi-physician urology group in the Mid-Atlantic offering comprehensive urology services including robotic surgery, oncology, and women's urology. Directly comparable as a multi-subspecialty urology group practice with hospital affiliations; now part of United Urology Group.
• Arizona Urology Specialists: Multi-location urology group practice serving the Phoenix metro area with comprehensive urology care including robotic surgery and radiation oncology. Direct comparable as a regional full-service urology group of similar structure.
• Genesis Healthcare Partners: Southern California urology group offering robotic surgery, radiation oncology, and comprehensive urological care across multiple locations. Comparable multi-subspecialty urology group structure.
• Urology of Virginia / Eastern Virginia Medical School: Large regional urology group in Virginia Tidewater region with academic affiliation; mentioned in Florida Urology Partners data as the endourology fellowship site for one of their physicians. Comparable as a multi-subspecialty urology group practice.

Broad incumbents

• U.S. Urology Partners: PE-backed national urology platform consolidating independent urology groups across multiple states. Directly comparable as a multi-state urology group practice business model; differs in scale and corporate ownership (Solar Capital-backed) rather than hospital alignment.
• Tampa General Hospital (TGH Cancer Institute): Parent/affiliate institution; academic-affiliated tertiary hospital system that Florida Urology Partners integrated with in 2021. Direct comparable as the institutional counterparty that drives tertiary referrals into Florida Urology Partners.

Others

• Axonics, Inc. Medical device manufacturer whose sacral neuromodulation technology is deployed at Florida Urology Partners (designated Axonics Center of Excellence). Comparable as a key technology partner supplying the neuromodulation platform used by the practice.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/florida-urology-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Florida Urology Partners